Second-line treatment in patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma: a systematic review and meta-analysis

BACKGROUND: There is no standard second-line treatment for patients with advanced extra-pulmonary poorly differentiated neuroendocrine carcinoma (EP-PD-NEC). This study explored data evaluating second-line treatment in these patients. METHODS: A search of MEDLINE and EMBASE identified studies report...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Adv Med Oncol
Autors principals: McNamara, Mairéad G., Frizziero, Melissa, Jacobs, Timothy, Lamarca, Angela, Hubner, Richard A., Valle, Juan W., Amir, Eitan
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Systematic Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7222242/
https://ncbi.nlm.nih.gov/pubmed/32426044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920915299
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars